In vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate

Polymyxin Resistance Caused bymgrBInactivation Is Not Associated with Significant Biological Cost in Klebsiella pneumoniae

(2015) Antonio Cannatelli et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Novel antibiotics: Are we still in the pre–post-antibiotic era?

(2015) R. Draenert et al.   INFECTION

Neurotensin Branched Peptide as a Tumor-Targeting Agent for Human Bladder Cancer

(2015) Jlenia Brunetti et al.   Biomed Research International

Site-specific pegylation of an antimicrobial peptide increases resistance to Pseudomonas aeruginosa elastase

(2014) Chiara Falciani et al.   AMINO ACIDS

Engineered Cationic Antimicrobial Peptides To Overcome Multidrug Resistance by ESKAPE Pathogens

(2014) Berthony Deslouches et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Update on the antibiotic resistance crisis

(2014) Gian Maria Rossolini et al.   CURRENT OPINION IN PHARMACOLOGY

The Development of Antimicrobial Peptides as New Antibacterial Drugs

(2014) Giulia Roscia et al.   CURRENT PROTEIN & PEPTIDE SCIENCE

Intra-abdominal Infections: Etiology, Epidemiology, Microbiological Diagnosis and Antibiotic Resistance

(2014) G. Nicoletti et al.   JOURNAL OF CHEMOTHERAPY

In VivoEmergence of Colistin Resistance in Klebsiella pneumoniae Producing KPC-Type Carbapenemases Mediated by Insertional Inactivation of the PhoQ/PhoPmgrBRegulator

(2013) Antonio Cannatelli et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Esculentin(1-21), an amphibian skin membrane-active peptide with potent activity on both planktonic and biofilm cells of the bacterial pathogen Pseudomonas aeruginosa

(2013) Vincenzo Luca et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

10 x '20 Progress--Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America

(2013) H. W. Boucher et al.   CLINICAL INFECTIOUS DISEASES

Respiratory bacterial infections in cystic fibrosis

(2013) Oana Ciofu et al.   CURRENT OPINION IN PULMONARY MEDICINE

Clinical relevance of the ESKAPE pathogens

(2013) Jack N Pendleton et al.   Expert Review of Anti-Infective Therapy

Clinical Use of Colistin Induces Cross-Resistance to Host Antimicrobials in Acinetobacter baumannii

(2013) B. A. Napier et al.   mBio

Changing bacteriology of abdominal and surgical sepsis

(2012) Yen-Hsu Chen et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Colistin: an update on the antibiotic of the 21st century

(2012) Silpak Biswas et al.   Expert Review of Anti-Infective Therapy

Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens

(2012) Chiara Falciani et al.   PLoS One

Current dilemmas in antimicrobial therapy in cystic fibrosis

(2012) Kamini Jain et al.   Expert Review of Respiratory Medicine

Pseudomonas Skin Infection

(2011) Douglas C. Wu et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

Efficacy and toxicity of the antimicrobial peptide M33 produced with different counter-ions

(2011) Alessandro Pini et al.   AMINO ACIDS

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

(2011) A.-P. Magiorakos et al.   CLINICAL MICROBIOLOGY AND INFECTION

Modular Branched Neurotensin Peptides for Tumor Target Tracing and Receptor-Mediated Therapy: A Proof-of-Concept

(2010) C. Falciani et al.   CURRENT CANCER DRUG TARGETS

A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo

(2009) Alessandro Pini et al.   FASEB JOURNAL

Colistin and Polymyxin B in Critical Care

(2008) Argyris Michalopoulos et al.   CRITICAL CARE CLINICS

Branched Peptides as Therapeutics

(2008) Alessandro Pini et al.   CURRENT PROTEIN & PEPTIDE SCIENCE